Stock Information
Ionis Pharmaceuticals Inc (IONS)
Ticker Symbol: IONS
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $13,144.22 mil
Piotroski score: 2
PE Ratio: N/A
EPS (TTM): -2.4657
Revenue (TTM): $5.81 M
Dividend Yield: N/A%
ROE: -68.89%
Latest News
-
The FDA Accepts For Priority Review Ionis Pharmaceuticals' New Drug Application For Zilganersen For Alexander disease, With PDUFA Date Of September 22, 2026
Mon, Mar 23, 2026 7:09 AM
-
Ionis Pharmaceuticals' Peak Olezarsen Revenues Are Likely Very Conservative
Fri, Mar 20, 2026 9:13 AM
-
Tracking Baker Brothers Portfolio - Q4 2025 Update
Tue, Mar 17, 2026 8:54 PM
-
Ionis Pharmaceuticals, Inc. (IONS) Presents at Stifel 2026 Virtual CNS Forum Transcript
Tue, Mar 17, 2026 4:22 PM
Key Financials
Financial data not available
